Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Active:	Yes
Cancer Type:	Unknown Primary	NCT ID:	NCT05919511
Trial Phases:		Protocol IDs:	MA-GVHD-401 (primary) NCI-2023-06770
Eligibility:	18 Years and older, Male and Female	Study Type:	Other
Study Sponsor:	Incyte Corporation
NCI Full Details:	http://clinicaltrials.gov/show/NCT05919511

Summary

The purpose of this prospective observational study is to collect data from participants
who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of
Chronic Graft Versus Host Disease(cGVHD)

Treatment Sites in Georgia

Georgia Cancer Center at Augusta University
1411 Laney Walker Boulevard
Augusta, GA 30912
www.augusta.edu/cancer/

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.